Current Net Margin
-33.61%
BioNTech SE currently has a net profit margin of -33.61%. Net margin is a key efficiency ratio that measures what percentage of each dollar of revenue actually results in profit for the company.
Historical Margin Data
Quarterly and annual profitability trends
| Date | Revenue ($B) | Net Income ($B) | Net Margin | Change (bps) |
|---|---|---|---|---|
| 2025-12-31 | 0.90 | -0.30 | -33.61% | ▼3172 |
| 2025-09-30 | 1.52 | -0.03 | -1.89% | ▲14635 |
| 2025-06-30 | 0.26 | -0.39 | -148.24% | ▲7923 |
| 2025-03-31 | 0.18 | -0.42 | -227.46% | ▼24927 |
| 2024-12-31 | 1.19 | 0.26 | 21.81% | ▲589 |
| 2024-09-30 | 1.24 | 0.20 | 15.91% | ▲64358 |
| 2024-06-30 | 0.13 | -0.81 | -627.66% | ▼45970 |
| 2024-03-31 | 0.19 | -0.32 | -167.96% | ▼19892 |
| 2023-12-31 | 1.48 | 0.46 | 30.96% | ▲1302 |
| 2023-09-30 | 0.90 | 0.16 | 17.94% | ▲13147 |
| 2023-06-30 | 0.17 | -0.19 | -113.54% | ▼15286 |
| 2023-03-31 | 1.28 | 0.50 | 39.33% | ▼1394 |
| 2022-12-31 | 4.28 | 2.28 | 53.26% | ▲169 |
| 2022-09-30 | 3.46 | 1.78 | 51.57% | ▼74 |
| 2022-06-30 | 3.20 | 1.67 | 52.31% | ▼572 |
| 2022-03-31 | 6.37 | 3.70 | 58.02% | ▲79 |
| 2021-12-31 | 5.53 | 3.17 | 57.23% | ▲448 |
| 2021-09-30 | 6.09 | 3.21 | 52.75% | ▲24 |
| 2021-06-30 | 5.31 | 2.79 | 52.50% | ▼257 |
| 2021-03-31 | 2.05 | 1.13 | 55.07% | ▼5114 |
| 2020-12-31 | 0.35 | 0.37 | 106.22% | ▲41733 |
| 2020-09-30 | 0.07 | -0.21 | -311.11% | ▼9936 |
| 2020-06-30 | 0.04 | -0.09 | -211.75% | ▼1897 |
| 2020-03-31 | 0.03 | -0.05 | -192.78% | ▲1525 |
| 2019-12-31 | 0.03 | -0.06 | -208.03% | ▼10300 |
| 2019-09-30 | 0.03 | -0.03 | -105.03% | ▲8921 |
| 2019-06-30 | 0.03 | -0.05 | -194.24% | ▼3883 |
| 2019-03-31 | 0.03 | -0.04 | -155.41% | ▼15329 |
| 2018-12-31 | 0.06 | -0.00 | -2.12% | ▲11276 |
| 2018-09-30 | 0.02 | -0.02 | -114.88% | ▼6134 |
| 2018-06-30 | 0.02 | -0.01 | -53.54% | 0 |
| 2018-03-31 | 0.02 | -0.01 | -53.54% | — |
* Net margin = (Net Income / Total Revenue) * 100. Based on official SEC filings.